The Discounted Cash Flow (DCF) valuation of Bioventus Inc (BVS) is (1.90) USD. With the latest stock price at 7.39 USD, the upside of Bioventus Inc based on DCF is -125.7%.
Based on the latest price of 7.39 USD and our DCF valuation, Bioventus Inc (BVS) is a sell. selling Bioventus stocks now will result in a potential gain of 125.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 13.4% | 10.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (2.84) - 3.70 | (1.90) |
| Upside | -138.5% - -49.9% | -125.7% |